Grants & Awards

ness Research Education Foundation for Women’s Canfor Women’s Cancer Gynecologic Cancer Awareness Rcer Awareness Research Education Foundation for Womndation for Women’s Cancer Gynecologic Cancer Awologic Cancer Awareness Research Education Foundah Education Foundation for Women’s Cancer GynecoCancer Gynecologic Cancer Awareness Research Eduness Research Education Foundation for Women’s Canfor Women’s Cancer Gynecologic Cancer Awareness Rcer Awareness Research Education Foundation for Womndation for Women’s Cancer Gynecologic Cancer Awologic Cancer Awareness Research Education Foundah Education Foundation for Women’s Cancer GynecoCancer Gynecologic Cancer Awareness Research Eduness Research Education Foundation for Women’s Canfor Women’s Cancer Gynecologic Cancer Awareness R2015–2016Grants &Awardser Awareness RESEARCH Education Foundation for Womndation for Women’s Cancer Gynecologic Cancer Awologic Cancer Awareness Research Education Foundah Education Foundation for Women’s Cancer GynecoCancer Gynecologic Cancer Awareness Research Eduness Research Education Foundation for Women’s Canfor Women’s Cancer Gynecologic foundationforwomenscancer.orgCancer Awareness Rcer Awareness Research Education Foundation for Wom

CONTENTS1 Introduction2 2015–2016 Foundation for Women’s Cancer Research GrantsBelinda Sue Fund/Mary-Jane Welker Ovarian Cancer Early Detection Research GrantCaring Together, NY Ovarian Cancer Research Synergy GrantOvarcome Ovarian Early Detection Cancer Research GrantSt. Louis Ovarian Cancer Awareness Research GrantWeRoc Ovarian Cancer Research Grant3 Research Grants Guidelines, Instructions and Application Process4 Checklist5 Research Grants Application6 Research Grants Budget7 Research Grants Frequently Asked Questions8 Foundation for Women’s Cancer/Norma Livingston Ovarian Cancer Foundation “Excellence in OvarianCancer Research Prize”9 Foundation for Women’s Cancer/Norma Livingston Ovarian Cancer Foundation “Excellence in OvarianCancer Research Prize” Application10 Carol’s Cause Awards for the Outstanding Papers by Residents or Fellows (Two winners will be chosen)ALL Candidate members who qualify for this award will automatically be included in the evaluation process; noapplication is necessary.11 The Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 201612 The Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2016 Application13 Dr. John L. Lewis, Jr./William F. O’Connor Foundation Research Prize and Application14 David M. Gershenson, MD Young Investigator Prize and Application15 Perlman Family CCARE Lynch Syndrome Research Prize and Application16 Research Grants and Awards History Report26 National Cancer Institute Fellows History Report26 National Cancer Institute Scholars History Report27 Recipients of Outstanding Paper by a Resident or Fellow Prizes History Report27 Foundation for Women’s Cancer/OCRF Grant for Early Detection of Ovarian Cancer History Report27 Perlman Family CCARE Lynch Syndrome Research Prize History Report28 Dr. John L. Lewis, Jr./William F. O’Connor Foundation Research Prize History Report28 John L. Lewis, Jr., MD Presidential Award History Report28 Margaret Greenfield/Carmel Cohen, MD “Excellence in Ovarian Cancer Research Prize” History Report29 Foundation for Women’s Cancer “Excellence in Ovarian Cancer Research Prize” History Report29 Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher HistoryReport

IMPORTANT DATESAugust 12, 2015All research grant abstracts must bereceived at Foundation Headquartersby this date to be eligible forconsideration.September 23, 2015Researchers will be notified iftheir abstract has qualified to beconsidered for a full grant proposal.October 28, 2015Full grant proposals due toFoundation HeadquartersPrize applications due to FoundationHeadquartersJanuary 2016Award winners will be notified.March 2016Winners presented with awards atSGO Annual Meeting.April 2016Research projects commence.October 3, 2016Interim progress reports due.July 10, 2017Final research results report to besubmitted to the Foundation.FOR FURTHER INFORMATION CONTACT:Foundation for Women’s Cancer230 W. Monroe Street, Suite 2528,Chicago, IL 60606-4902Phone: 312.578.1439Fax: 312.578.9769research@foundationforwomenscancer.orgJuly 2015Dear Researcher,The Foundation for Women’s Cancer and I invite you to apply for its2015–2016 research grants and awards.The Research Grants and Awards program has proven tobe extremely effective in achieving its goal of mentoring andaccelerating the success of young investigators. Those selected toreceive these stimulus grants opt for careers as physician-scientists(94%), publish research results in peer-reviewed publications, andare able to leverage the initial Foundation grant support to attractother funding, including NIH RO1 grants, with a 23-fold return on theinitial grant amount.To build upon our success, we are looking at expanded opportunitiesfor you. This is a time of great opportunity and challenge forgynecologic cancer research.The Foundation for Women’s Cancer Research Grants and AwardsCommittee continues to seek additional funding to support expandedresearch priorities. These research priorities complement the Societyof Gynecologic Oncology (SGO) Research Summit report, “Pathwaysto Progress.” Of special importance is increased funding for cervical,uterine, primary peritoneal, vaginal and vulvar cancer research. Wewelcome your suggestions about potential sponsors.Additionally, the Foundation is seeking funding for a series of newtypes of research opportunities.• Innovative grants: These grants would provide funding for creativeand imaginative research proposals that are not sufficientlyadvanced or developed to obtain funding from traditional sources.• Paired grants: Junior investigators would join with seniorinvestigators for grants lasting two to three years.• Extend the current, highly successful stimulus or “seed” grantprogram to include all gynecologic cancers, and offer theopportunity for competitive renewals at the conclusion of the oneyearresearch grant.This year’s brochure contains a list of funding opportunities anddetailed instructions about the application process. The Foundation’sResearch Grants and Awards Committee, listed below, carefullyconsiders each application — always a challenge given thecompetitive nature of the program.Please consider applying to become part of an elite group ofsuccessful physician-scientists committed to the well-being of womenat risk for, and those who are affected by, gynecologic malignancies.Sincerely,Anil K. Sood, MDFoundation for Women’s CancerResearch Grants & Awards Committee Chairman1

2015–2016 FOUNDATION FOR WOMEN’S CANCERRESEARCH GRANTSBelinda Sue Fund/Mary-Jane WelkerOvarian Cancer Early DetectionResearch Grant$50,000/ (1) Year Award• Related to early detection in ovarian cancer.The Foundation gratefully acknowledges the Belinda SueFund and the Welker Family for the support of this grant.This is the first combined research grant supported bythe Belinda Sue Fund and the Welker Family.Caring Together, NY Ovarian CancerResearch Synergy Grant$100,000/ (2) Year Award• Related to ovarian cancer.The Foundation gratefully acknowledges CaringTogether, Inc. of New York for the support of this grant.This is the seventh research grant supported by CaringTogether, NY.St. Louis Ovarian Cancer AwarenessResearch Grant$75,000/ (1) Year Award• Related to ovarian cancerThe Foundation gratefully acknowledges St. LouisOvarian Cancer Awareness (SLOCA) for the support ofthis grant. This is the eleventh research grant supportedby SLOCA.WeRoc Ovarian Cancer Research Grant$50,000/ (1) Year Award• Related to ovarian cancerThe Foundation gratefully acknowledges WeRoc(Women Encouraging Research in Ovarian Cancer)for the support of this grant. This is WeRoc’s secondresearch grant with the Foundation and the first fullyfunded by WeRoc..Ovarcome Ovarian Cancer EarlyDetection Research Grant$25,000/ (1) Year Award• Related to early detection in ovarian cancer.The Foundation gratefully acknowledges Ovarcomefor support of this grant. This is the first research grantsupported by Ovarcome.2

RESEARCH GRANTS GUIDELINES, INSTRUCTIONSAND APPLICATION PROCESSOn behalf of the Foundation for Women’s Cancer andits Research Grants & Awards Committee, below youwill find the criteria to consider when submitting yourapplication to Foundation Headquarters:a. The Foundation will accept one (1) application perperson per year.b. Anyone who receives a grant as a resident or fellowis eligible to apply for another one time grant in thefuture.c. The Foundation will fund the best project applications,with priority given to young investigators. Younginvestigators are defined as those individuals whohave not been previously funded by the Departmentof Defense, American Cancer Society or the NationalCancer Institute in this area. Exceptions to thesecriteria may be made upon approval of the committee.d. SGO members (Full, Candidate, and Associate)who apply should be junior investigators, generallyAssistant Professor and below. Priority will be given tojunior investigators.e. Non-members of SGO may apply with a coinvestigatorwho is a SGO member. The goal of suchcollaborative applications is to foster collaborationand mentorship of an investigator new to the field.It is important for the applicant to document thisrelationship.f. Significant overlap with existing funding is notpermitted. Applicants should note the existence ofpending applications with potential overlap and aplan for how such overlap would be managed if bothapplications were funded.g. Abstracts should be written to allow a reviewer intranslational gynecologic research to interpret theaims and methods.h. Budget is not to be requested for the investigator’stime or effort. Budget for presentation/publication/travel is not allowed.i. The grant can be portable provided a similar researchenvironment is secured. Continued funding will becontingent upon ability to complete the proposed work.j. Research being done outside of the United States willnot be considered for funding; however, a non-U.S.resident may apply for a grant for research being doneat an American institution.k. All researchers must first submit a 250-word technicalabstract for scientific review. The best abstracts will beinvited to submit a full grant proposal, with a 250-wordpublic abstract for donor review and press releases,using non-scientific terms and include the author’sname and institution.l. All winners will be asked to present an annual updateon their research.INSTRUCTIONS:General:a. The abstract, the research grant application and thefull grant proposal, if invited, should be submittedusing 10-point Arial font and include the author’s nameand institution on each page.b. Handwritten applications will not be accepted.Abstracts:a. A signed original application (electronic signature isacceptable) using the form on page 5 is required.b. As described earlier, the abstract consists of a 250-word technical document for scientific review by thecommittee. Note that it should be written in a mannerto allow a reviewer in translational gynecologicresearch to interpret the aims and methods. It ismandatory to include the author’s name and institutionon the abstract.c. An updated CV.d. The signed application, CV and abstractshould be emailed in one pdf file to research@foundationforwomenscancer.org on or before4pm Central Daylight Time on August 12, 2015.The subject line should read Foundation ResearchGrant Application.3

Research Grant Full Proposal:a. A copy of the original application that was submitted isrequired.b. The research grant proposal should include theprincipal investigator’s first name, last name andcredentials in the upper right corner on all pages. Thedescription of the research should be no longer than(5) typed (8.5 x 11) pages, single-sided.c. The investigator’s bio sketch must be included.The bio sketch should state the total number ofpublications but, list no more than 15.d. A budget, using the form on page 6, must besubmitted along with a description of any otherfinancial support.e. A short paragraph describing institutional support,career goals and how this grant would help theapplicant achieve these goals is required with the fullgrant submission.f. No more than (3) letters of support are invited.g. A 250-word public abstract for donor review and pressreleases, using non-scientific terms, must be includedin a Word document.h. The Foundation requires an interim report in a Worddocument of 3 to 6 paragraphs to describe progress todate which will be due October 3, 2016 with the finalreport due July 10, 2017. The Foundation will also askfor annual updates in a Word document if chosen as awinner of the grant.i. The signed application along with all of thecomponents of the full proposal should be e-mailedto research@foundationforwomenscancer.orgon or before 5pm Central Daylight Time on October28, 2015. The subject line should read FoundationResearch Grant Proposal.Please note: If any information is missing or directionsare not followed appropriately when submitting theabstract, it will be returned with an explanation, providedit is received at least seven (7) days or more prior tothe application deadline. The applicant will then havethe opportunity to resubmit the proposal before thedeadline of October 28, 2015. If the applicant acceptsanother grant after submitting a full proposal and prior tonotification from the Foundation, please email research@foundationforwomenscancer.org so that the applicantwill be removed from the list of potential winners.CHECKLISTABSTRACT❍❍❍❍❍❍❍❍Signed original application (electronicsignature is acceptable) using the form onpage 5.An abstract that consists of 250-wordtechnical document for a scientific reviewby the committee.An updated CV.One attachment including all threedocuments (application, abstract and CV)should be submitted.RESEARCH GRANT PROPOSAL(if invited)❍❍❍❍❍❍A copy of the original application that wassubmitted.Description of the research.Investigator’s bio sketch.❍❍Budget (using form on page 6).❍❍❍❍❍❍❍❍Other financial support.Paragraph describing institutional support,career goals and how this grant wouldhelp the applicant.No more than three (3) letters of support.A 250-word public abstract geared forunderstanding by the general public in aWord document.4

RESEARCH GRANT APPLICATIONInvestigator Information (please print or type)NAME OF INVESTIGATOR BIRTHDATE CITIZENSHIPINVESTIGATOR’S PRESENT INSTITUTION INSTITUTION EIN #INVESTIGATOR’S PRESENT ACADEMIC RANK/TITLEDEGREEINVESTIGATOR’S DEPARTMENTCURRENT MAILING ADDRESSTELEPHONE FAX E-MAIL ADDRESSCO-INVESTIGATOR BIRTHDATE CITIZENSHIPPROJECT TITLECURRENT MEMBERSHIP CATEGORY OF SGOSIGNATURE OF INVESTIGATORNAME OF DIVISION OF GYNECOLOGIC ONCOLOGY CHAIRSIGNATURENAME/TITLE OF RESPONSIBLE INSTITUTION (if different from present institution)NAME OF GRANTS/CONTRACTS OFFICIAL TO BE NOTIFIED IF AWARDEDGRANTS/CONTRACTS OFFICIAL’S TITLECURRENT MAILING ADDRESSTELEPHONE FAX E-MAIL ADDRESSSIGNATURE OF GRANTS/CONTRACTS OFFICIAL TO BE NOTIFIED5

RESEARCH GRANT BUDGETINVESTIGATOR’S NAMEDETAILED BUDGET FOR INITIAL BUDGET PERIOD FROM THROUGHPersonnel DIRECT COSTS ONLY 04/01/16 03/31/17NameRole onProjectType ofAppointment*% Efforton ProjectInstitutionBase Salary**SalaryRequested forthis ProjectFringeBenefits* This column requires type of position or current level rather than time.** Institution base salary must be capped at the NIH cap. SUBTOTAL: $OTHER EXPENSES (Itemize by category) $Equipment Supplies Consultants OtherTOTAL DIRECT COSTS FOR INITIAL BUDGET PERIOD $BUDGET JUSTIFICATION:(THIS FORM MUST BE ENCLOSED WITH THE FULL PROPOSAL)NOTE: Budget submitted with the research grant application should be based on $50,000 total costs.***Grants may not include indirect costs or PI time***6

FOUNDATION FOR WOMEN’S CANCER RESEARCHGRANTS FREQUENTLY ASKED QUESTIONSPlease read the following section of Frequently Asked Questions to assist you in completing your grant application.If you have any questions that are not answered in this section, please contact the Foundation at research@foundationforwomenscancer.org.I am a foreign national working in the United States.Am I still eligible to receive a Foundation ResearchGrant?Yes, regardless of your nationality, you are eligible toreceive a Foundation Research Grant as long as yourresearch is being conducted in the United States.What constitutes indirect costs as referenced in thenote on the detailed budget form?Indirect costs include, but are not limited to,administrative cost of the university, usual criteriaestablished for grant overhead or other costs, suchas laboratory space.Grant monies must be devoted to the active researchproject.Do I need to include a cover letter with myapplication?No, the application form itself serves as the cover letter.I have previously received a Foundation ResearchGrant. Am I eligible to serve as a co-investigator onan application?Yes, past grant recipients are eligible to serve as coinvestigator;however, they are not eligible to apply asprimary investigators unless they received their grantas a resident or fellow.I’m not a full faculty member; am I still eligible toapply for a grant?Yes, instructors, associate professors and assistantprofessors are all eligible to apply for Foundation grants.Do I need to submit letters of support along with myfull grant application?Yes. No more than three (3) letters of support should beincluded.Why do I need to include my institution’s federalidentification number?All grant monies are made payable in a check to therecipient’s institution. The Foundation is responsible forsubmitting the institution’s federal identification numberfor tax purposes at the end of the year.Are non-physician PhD’s eligible to apply for a grant?Yes, non-physician PhD’s are eligible to apply for grantsprovided they have a co-sponsor who is a board certifiedgynecologic oncologist who is a member of the Society ofGynecologic Oncology.Can an individual serve as a co-investigator for morethan one applicant?Yes, an individual may be the co-investigator for morethan one grant.Do I apply for a specific grant?No, the application should be for either ovarian cancerresearch or early detection ovarian cancer research. TheResearch Grants and Prizes Committee will decide whichgrant matches the applicant.How much should the budget reflect?The budget should reflect $50,000.00.Do I need to send in a full application initially?No, abstracts are due by August 12, 2015, and then IFinvited to submit a full proposal, it will be required byOctober 28, 2015.7

FOUNDATION FOR WOMEN’S CANCER/NORMALIVINGSTON OVARIAN CANCER FOUNDATION“EXCELLENCE IN OVARIAN CANCER RESEARCHPRIZE”This annual $5,000 prize is funded by the NormaLivingston Ovarian Cancer Foundation in honor of RonaldAlvarez, MD.This prize will be given to an individual who can bestdemonstrate that he or she has been able to use theirFoundation award to improve women’s health care.This would be through obtaining independent extramuralfunding, making important contributions to the literature,and/or developing programs that improved women’shealth care, including early detection. This award is tothe individual and not his/her institution.The Foundation’s Research Grants & Award’s Committeewill determine a winner based on previously statedcriteria. The prize will be announced at the 2016 SGOAnnual Meeting on Women’s Cancer in San Diego, CA.The Foundation gratefully acknowledges the NormaLivingston Ovarian Cancer Foundation for their generoussupport of this prize. This is the fifth prize supported bythe Norma Livingston Ovarian Cancer Foundation.Only past Foundation award winners qualify for thisprize and should apply by filling out the applicationform found on page 9 of this research booklet. Pleasee-mail your completed application to research@foundationforwomenscancer.org. Please reference“Excellence in Ovarian Cancer Prize” in the subject line.The deadline for applications is October 28, 2015.8

FOUNDATION FOR WOMEN’S CANCER/NORMALIVINGSTON OVARIAN CANCER FOUNDATION“EXCELLENCE IN OVARIAN CANCER RESEARCHPRIZE” APPLICATIONNAME:LAST FIRST MIDDLEADDRESS:TELEPHONE:OFFICE:HOME:FAX:E-MAIL:TITLE OF RESEARCH GRANT:AMOUNT OF GRANT:YEAR GRANT WAS AWARDED:MEDICAL SCHOOL EDUCATION:SCHOOLDEGREE & DATE OF GRADUATIONOTHER GRADUATE EDUCATION:NAMEDEGREE & DATE OF COMPLETIONOTHER INFORMATION:1. 1–2 PAGE SINGLE SPACED PROPOSAL TYPED IN 10-POINT ARIAL FONT IN A WORD DOCUMENT2. ATTACH UPDATED C.V.Please return this application by October 28, 2015 to research@foundationforwomenscancer.org9

CAROL’S CAUSE AWARDS FOR THE OUTSTANDINGPAPERS BY RESIDENTS OR FELLOWSIMPORTANT NOTE: All Candidate members who qualify for this award based on above criteria will automatically beincluded in the review process. No application is needed.ELIGIBILITYCandidates for these awards must have performed theresearch during residency in obstetrics and gynecologyor during their fellowship training in gynecologic oncology,and also must be a trainee at the time the abstractis submitted. The abstract must have been acceptedby the Program Committee for an oral presentation.The candidate must be the sole or first author of themanuscript. The work must be a report of clinical orbasic research. Manuscripts may not be a review ofwork performed by others. Papers already published arenot eligible for consideration. A paper may be submittedfor publication after the abstract is sent to the ProgramCommittee, but may not appear in print prior to the SGO2016 Annual Meeting on Women’s Cancer. Americanapplicants must be enrolled in an American Board ofObstetricians and Gynecologists approved fellowshipprogram in gynecologic oncology. Foreign applicantsmust be enrolled in a similar program.AWARDThere will be two Carol’s Cause Awards for theOutstanding Paper by a Resident or Fellow. The winnerswill be announced following the SGO Annual Meeting onWomen’s Cancer. The two winners of the Carol’s CauseAward will receive $3,500 each.The Foundation gratefully acknowledges the Carol’sCause organization for their support of this award throughan educational grant over the past ten years.SELECTION PROCESSAll Residents and Fellows-In-Training should submitabstracts to the SGO Program Committee and indicatetheir residency or fellowship status in their abstractsubmission. As soon as the Program Committee hasselected its program, all qualified abstracts for this awardwill be submitted to the Foundation Awards Committeefor review. ALL CANDIDATES WHO QUALIFY FORTHIS AWARD BASED ON ABOVE CRITERIA WILLAUTOMATICALLY BE INCLUDED IN THE EVALUATIONPROCESS. Each accepted applicant must submit acomplete manuscript within the time frame stipulated bythe Program Committee. Manuscripts will be distributedto the Foundation Research & Awards Committee forreview prior to the meeting and a scoring sheet will becompleted. The scoring will be based on study design,originality, scientific merit, importance to the field andpresentation. After the 2016 SGO Annual Meeting onWomen’s Cancer, the Foundation Research & AwardsCommittee will meet and select the outstanding paper.10

THE CLAUDIA COHEN PRIZE FOR OUTSTANDINGGYNECOLOGIC CANCER RESEARCHER 2016The Claudia Cohen Research Foundation Prize forOutstanding Gynecologic Cancer Researcher is a$50,000 annual prize awarded to an individual inrecognition of his or her outstanding contributions toresearch to improve the care of women with gynecologiccancer. The selected awardees will have made importantcontributions to research which have improved the earlydetection, treatment, or prevention of gynecologiccancer.The prize was first awarded in 2010 in honor of ClaudiaCohen who lost her battle with uterine leiomyosarcoma in2007. Ms. Cohen was a highly respected journalist andphilanthropist. The Claudia Cohen Research Foundationwas founded by Ms. Cohen’s daughter Samantha,and her sisters Caleigh and Debra Perelman to fosterresearch aimed at reducing the burden of gynecologiccancer.The prize is announced annually at the Society forGynecologic Oncology Annual Meeting in March 2016.Selection Criteria:The applicant must demonstrate they have:1. Made important contributions to research improvingthe care of women with gynecologic cancer.2. Obtained significant independent extramural researchfunding.3. Made significant contributions to literature in the field.4. Developed programs that improved women’s health.Eligibility:All applicants must:1. Demonstrate body of research in gynecologic cancer,and outline, if relevant, any application to gynecologicsarcoma.2. Possess an academic appointment in the USA.3. Hold either an M.D. degree or Ph.D. degree orequivalent.Application Process:1. The Application Form detailing: name of candidate,date of birth, address, phone, fax, email, universityaffiliation and academic rank.2. Their NIH BioSketch / Curriculum Vitae3. Abstracts of the applicant’s 3 most recently publishedor relevant peer-reviewed papers.4. A letter of support or nomination from a seniorcolleague in the field5. A Personal Statement describing their researchaccomplishments and the impact on either earlydetection, prevention or therapeutics for womenaffected by gynecologic cancer, which answers thefollowing questions in 400 words each:1. How has your research contributed toimproving the care of women with gynecologiccancer?2. What do you consider your greatestachievement, and how has this positivelyimpacted patients and the field of gynecologiccancer?3. What significant independent extramuralresearch funding have you obtained duringyour career?4. What significant contributions have you madeto research literature in the field of gynecologiconcology?5. Describe how your work has developedspecific programs, treatments or protocolswhich have improved the health of womenaffected by gynecologic cancer.How to apply:- Complete the Application Form- Email your completed application to research@foundationforwomenscancer.org.- Please reference Claudia Cohen Research Prize inthe subject line.- The deadline for entries is October 28, 2015.- All applications must be in English.Please note:- The award will be made to the individual rather thanhis/her institution.- Individuals may apply for the prize, or nominatorscan propose potential candidates by filing in theapplication form on page 12.The Foundation gratefully acknowledges the ClaudiaCohen Research Foundation for its generous supportof this annual prize. This is the seventh annual ClaudiaCohen Prize for Outstanding Gynecologic CancerResearcher.11

THE CLAUDIA COHEN PRIZE FOR OUTSTANDINGGYNECOLOGIC CANCER RESEARCHER 2016APPLICATIONCANDIDATE CONTACT INFORMATIONNAME:FIRST MIDDLE LASTPROFESSIONAL TITLE (MD, PhD, Other):ADDRESS:CITY: STATE: ZIP:OFFICE PHONE:HOME PHONE:CELL PHONE:E-MAIL ADDRESS:TYPE OF RESEARCHRESEARCH SPECIALTY: Prevention Early Detection TherapeuticsRESEARCH FOCUS:RESEARCH APPROACH: Basic Science Translational ScienceImmunologyPrecision MedicineTRAININGMEDICAL SCHOOL EDUCATION:SCHOOL:DEGREE:DATE OF GRADUATION:OTHER GRADUATE EDUCATION:SCHOOL:DEGREE:DATE OF COMPLETION:12

DR. JOHN L. LEWIS, JR./WILLIAM F. O’CONNORFOUNDATION RESEARCH PRIZEFunding is available for a $1,000 prize to a fellow or resident who has promise to contribute to the field of gynecologiconcology in the future.The Foundation gratefully acknowledges the William F. O’Connor Foundation, Joanne Unkovskoy, Trustee, for itsgenerous support of this annual prize. This is the third prize being supported by the William F. O’Connor Foundation.APPLICATIONNAME:LAST FIRST MIDDLEADDRESS:TELEPHONE:OFFICE:HOME:FAX:E-MAIL:MEDICAL SCHOOL EDUCATION:SCHOOL:DEGREE & DATE OF GRADUATION:OTHER GRADUATE EDUCATION:NAME:DEGREE & DATE OF COMPLETION:OTHER INFORMATION:1. 1–2 PAGE SINGLE SPACED PROPOSAL TYPED IN 10-POINT ARIAL FONT IN A WORD DOCUMENTNote: Proposal should explain how you plan to contribute to the field of gynecologic oncology2. ATTACH UPDATED C.V.Please return this application by October 28, 2015 to research@foundationforwomenscancer.org13

DAVID M. GERSHENSON, MD YOUNGINVESTIGATOR PRIZEFunding is available for a $1,000 prize to a fellow or resident who has promise to contribute to the field of gynecologiconcology in the future.The Foundation gratefully acknowledges the Dickens Fund of the Donnelley Foundation, for its generous support of thisprize. This is the first prize being supported by the Dickens Fund of the Donnelley Foundation.APPLICATIONNAME:LAST FIRST MIDDLEADDRESS:TELEPHONE:OFFICE:HOME:FAX:E-MAIL:MEDICAL SCHOOL EDUCATION:SCHOOL:DEGREE & DATE OF GRADUATION:OTHER GRADUATE EDUCATION:NAME:DEGREE & DATE OF COMPLETION:OTHER INFORMATION:1. 1–2 PAGE SINGLE SPACED PROPOSAL TYPED IN 10-POINT ARIAL FONT IN A WORD DOCUMENTNote: Proposal should explain how you plan to contribute to the field of gynecologic oncology2. ATTACH UPDATED C.V.Please return this application by October 28, 2015 to research@foundationforwomenscancer.org14

PERLMAN FAMILY CCARE LYNCH SYNDROMERESEARCH PRIZEFunding is available for a $1,500 stipend for a trainee to support a summer or short-term research project that advancesknowledge about Lynch Syndrome and its role in gynecologic cancers. The successful applicant must submit a shortsummary of the projects goals and expected outcomes co-signed by the applicant’s mentor and supervisor.The Foundation gratefully acknowledges the Perlman Family for its generous support of this prize. This is the fourthprize being supported by the Perlman Family.APPLICATIONNAME:LAST FIRST MIDDLEADDRESS:TELEPHONE:OFFICE:HOME:FAX:E-MAIL:TITLE OF LYNCH SYNDROME PROJECT:YOUR SIGNATURE:SIGNATURE OF MENTOR/SUPERVISOR:ADDRESS:TELEPHONE:OFFICE:HOME:FAX:E-MAIL:MEDICAL SCHOOL EDUCATION:SCHOOLDEGREE & DATE OF GRADUATIONOTHER GRADUATE EDUCATION:NAME:DEGREE & DATE OF COMPLETION:OTHER INFORMATION:1. 1–2 PAGE SINGLE SPACED PROPOSAL TYPED IN10-POINT ARIAL FONT IN A WORD DOCUMENT2. ATTACH C.V.Please return this application by October 28, 2015to research@foundationforwomenscancer.org15

Research Grants and Awards History ReportRECIPIENT INSTITUTION AWARD AMOUNT TITLEBeth Karlan, MDCedars-Sinai Medical CenterLos Angeles, CAKarin Smith ResearchGrant in Ovarian Cancer$50,000“Characterization of a NovelOvarian Inhibitory Substance”1995–1996Jeffrey Fowler, MDOhio State UniversityColumbus, OHGCF Research Grant inSurgery$50,000“Laparoscopy Versus Laparotomy:An Evaluation of AdhesionFormation after Pelvic andParaaortic Lymphadenectomy in aPorcine Model”1996–1997Stephen Rubin, MDT. Scott Jennings, MDUniversity of PennsylvaniaPhiladelphia, PACardina GynecologicOncologyCharleston, SCKarin Smith ResearchGrant in Ovarian CancerGCF Research Grant inSurgery$50,000$50,000“Adenovirus-Mediated GeneTherapy of Human OvarianCancer”“Comparative Study of Crystalloidvs. Albumin Replacement inPatients with Ovarian Cancer andAscites”Andrew Berchuck, MDDuke University MedicalCenterDurham, NCKarin Smith ResearchGrant in Ovarian Cancer$50,000“Molecular-Epidemiology ofOvarian Cancer”1997–1998Richard Buller, MD, PhDJean Hurteau, MDUniversity of IowaIowa City, IAUniversity HospitalIndianapolis, INFlorence & MarshallSchwid Ovarian CancerResearch GrantEva Metzger ResearchGrant in Ovarian Cancer$50,000$50,000“Modulation of BRCA1 Expressionin Ovarian Cancer: ScreeningRamifications”“Regulation of Ovarian CancerCell Growth with CyclinDependent Kinase Inhibitor GeneTherapy”Judith Wolf, MDThe University of TexasMD Anderson CancerCancerHouston, TXGCF Research Grant inGynecologic Cancer$25,000“Evaluation of the Effectand Mechanism of Action ofAdenovirus-Mediated TumorSuppressor Gene Therapy ofOvarian Cancer”1998–1999Pamela Paley, MDUniversity of WashingtonSeattle, WAFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“A Molecular Fingerprint ofAngiogenesis in Epithelial OvarianCancer”1999–2000Terri Pustilnik,MDUniversity of AlabamaBirmingham, ALFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“A Dendritic Cell-based VaccineStrategy for Ovarian CarcinomaUsing the Novel Ovarian TumorMarker Mesothelin”16

Research Grants and Awards History Report (continued)RECIPIENT INSTITUTION AWARD AMOUNT TITLES. Diane Yamada, MDUniversity of ChicagoChicago, ILFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“Evaluation of MKK4/SEKIMetastasis Suppressor Gene inOvarian Carcinoma”2000–2001George Coukos, MD,PhDUniversity of PennsylvaniaPhiladelphia, PABristol-Myers SquibbOncology YoungInvestigator Grant$50,000“Impact of CytotoxicChemotherapy on VaccineTherapy Strategies in EpithelialOvarian Cancer”Anil Sood, MDUniversity of IowaIowa City, IANOCC Ovarian CancerResearch Grant$50,000“Role of FAK Expression inInvasion and Progression”2000–2002Ilana Cass, MDCedars-Sinai Medical CenterLos Angeles, CASusan G. Komen BreastCancer FoundationCareer DevelopmentGrant$50,000for2 yrs.“Effect of P53 Mutation Statuson Cisplatin Chemosensitivityin Carcinomas with BRCA1Mutations”Elizabeth Swisher, MDUniversity of WashingtonSeattle, WAFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“Impact of Epigenetic Modulationof DNA Repair Genes onChemoresistance and Survival inOvarian Cancer”2001–2002Warner Huh, MDUniversity of AlabamaBirmingham, ALBristol-Myers SquibbOncology YoungInvestigator Grant$50,000“Transduced Dendritic CellTherapy for Cervical Cancer —Alternative Vector Targeting andConjugate Strategies”William Cliby, MDMayo ClinicRochester, MNNOCC Ovarian CancerResearch Grant$50,000“Validation of an Avian OvarianCancer Model”Thomas Randall, MDPennsylvania HospitalPhiladelphia, PAFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“Immunoregulatory Function ofTumor Endothelium”Laura Havrilesky, MDDuke University MedicalCenterDurham, NCAnn Schreiber OvarianCancer Research Grant$50,000“Acetaminophen for the PrimaryPrevention of Ovarian Cancer”2002–2003J. Rebecca Liu, MDUniversity of MichiganAnn Arbor, MISusan G. Komen BreastCancer FoundationCareer DevelopmentGrant$50,000for2 yrs.“Resveratrol Induced Apoptosisand Autophagocytosis in Ovarianand Breast Cancer”David Cohn, MDOhio State UniversityColumbus, OHOvarian CancerResearch Grant$50,000“Active Immunization with VEGFPeptides in the Treatment andPrevention of Ovarian Cancer”Sharmila Makhija, MDUniversity of AlabamaBirmingham, ALOvarian CancerResearch Grant$50,000“Transcriptional TargetedAntiangiogenesis Gene Therapyfor Ovarian Carcinoma”17

Research Grants and Awards History Report (continued)RECIPIENT INSTITUTION AWARD AMOUNT TITLERobert Giuntoli, II, MDJohns Hopkins MedicalInstitutionsBaltimore, MDAnn Schreiber OvarianCancer Research Grant$50,000“Ex Vivo Expansion andIdentification of Ovarian CancerCytotoxic T Lymphocytes”Eugene Toy, MDUniversity of RochesterRochester, NYCytyc CorporationGynecologic CancerGrant$50,000“PDIP38, a Novel Protein Markerfor Early HPV Infection”Matthew Anderson, MDThe University of TexasMD Anderson CancerCancerHouston, TXEli Lilly and CompanyOvarian CancerResearch Grant$25,000“Dissecting the Role of AIB-1 inOvarian Epithelial Invasiveness”2003–2004Cheryl Saenz, MDLinda Duska, MDUniversity of CaliforniaSan Diego, CAMassachusetts GeneralHospitalBoston, MAFlorence & MarshallSchwid Ovarian CancerResearch GrantGlaxoSmithKlineOvarian CancerResearch Grant$50,000$25,000“Treatment of Terminal MetastaticOvarian Cancer by TransducibleTherapeutic siRNAs”“Testing the Significanceof Cables Expression inIdentifications and Genes ofEndometrial Cancer”Ronald Alvarez, MDUniversity of AlabamaBirmingham, ALKea Simon OvarianCancer Research Grant$50,000“Melanoma DifferentiationAssociated-7 (mda-7) Gene: ANovel Multifunctional Anti-TumorAgent for Ovarian Cancer”Robert Burger, MDUniversity of California —Irvine Medical CenterOrange, CAKea Simon OvarianCancer Research Grant$25,000“The Role of ECA1 in OvarianCarcinogenesis and PotentialUtility as a Serum Marker”Christina Chu, MDUniversity of PennsylvaniaPhiladelphia, PAOvarian CancerResearch Grant$50,000“Modification of Ovarian Tumorto Function as Primary AntigenPresenting Cells for AllogeneicVaccination”Rosemarie Schmandt,PhDThe University of TexasMD Anderson CancerCancerHouston, TXAnn Schreiber OvarianCancer Research Grant$50,000“What is the Role of BRK inOvarian Tumor Growth?”2004–2005Mark Einstein, MDJoseph Connor, MDAlbert Einstein Collegeof MedicineBronx, NYUniversity of WisconsinMadison, WIAnonymous CervicalCancer Research GrantAnonymous OvarianCancer Research Grant$25,000$50,000“Role of Genetic Variants inCervical Cancer Risk”“Intraperitoneal Therapy withhuKS-IL2 in a Mouse Model ofEpithelian Ovarian Cancer”David O’Malley, MDYale University Schoolof MedicineNew Haven, CTEli Lilly & CompanyOvarian CancerResearch Grant$50,000“Characterize the MolecularMechanisms Regulating theSensitivity of Ovarian Cellsto Apoptosis Induced byPhenoxodiol”18

Research Grants and Awards History Report (continued)RECIPIENT INSTITUTION AWARD AMOUNT TITLEAmir Jazaeri, MDUniversity of VirginiaCharlottesville, VAFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“Evaluation of the MEIS1 Gene asPotential Biomarker for OvarianCancer”John Chan, MDStanford University Schoolof MedicineStanford, CAGlaxoSmithKlineTherapeutic Approachesto Relapsed OvarianCancer Grant$25,000“Dual Therapy of EpithelialOvarian Cancer”Andrew Li, MDCedars-Sinai Medical CenterLos Angeles, CAKea Simon OvarianCancer Research Grant$50,000“Androgen Modulation of EGFRSignaling in Epithelial OvarianCancer Biology”2004–2005Christine Walsh, MDCedars-Sinai Medical CenterLos Angeles, CALee Kaplan CancerFoundation OvarianCancer Research Grant$25,000“Defining the Role of HNPCC inWomen with Synchronous Ovarianand Endometrial Cancers”Johnathan Lancaster, MDMoffitt Cancer CenterTampa, FLMolly Cade OvarianCancer Research Grant$50,000“Reversal of Platinum Resistancein Ovarian Cancer Cell Lines bySilencing of Gene ExpressionPathways using RNA Interference”Peter Argenta, MDUniversity of MinnesotaMinneapolis, MNSusan G. Komen BreastCancer FoundationCareer DevelopmentGrant$50,000for 2 yrs.“The Relative Expression andActivity Levels of Steroid-Converting Enzyme Isoforms inBreast and Ovarian Cancers”Heidi Gray, MDUniversity of WashingtonSeattle, WAR.O.C.C.S. OvarianCancer Research Grant$25,000“Early Cancer Detection in HighRisk Patient using an OvarianCancer Specific ImmunologicScreen”Robert Coleman, MDThe University of TexasMD Anderson CancerCenterHouston, TXFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“Therapeutic Gene Silencing withsiRNA in Ovarian Carcinoma”Ernst Lengyel, MD, PhDUniversity of ChicagoMedical CenterChicago, ILMolly Cade OvarianCancer Research Grant$50,000“Establishment of a Peritoneal 3DCulture to Investigate Attachmentand Invasion of Ovarian CancerCells”2005–2006Gloria Huang, MDAlbert Einstein Collegeof MedicineBronx, NYKea Simon OvarianCancer Research Grant$50,000“Role of Insulin-Like GrowthFactor Signaling as a NovelTherapeutic Target in OvarianCancer”Takiko Daikoku, PhDVanderbilt UniversityMedical CenterNashville, TNAnn Schreiber OvarianCancer Research Grant$50,000“PPARs is a Downstream Targetof COX-1 Dervied Prostaglandinsin Ovarian Cancer”Kerry Rodabaugh, MDRoswell Park CancerInstituteBuffalo, NYAnonymous OvarianCancer Research Grant$50,000“Genomic Rearrangement: TheirAssociation with HereditaryOvarian Cancers & GeneticTesting”19

Research Grants and Awards History Report (continued)RECIPIENT INSTITUTION AWARD AMOUNT TITLEMelissa Merritt, PhDBrigham and Women’sHospitalBoston, MAOvarian CancerResearch Grant$50,000“Role of Ovarian StromalMicroenvironment in CarcinogenicTransformation of PutativePrecursor Cells for Pelvic SerousCancer”2007–2008Sanaz Memarzadeh, MDKathleen Moore, MDUniversity of California —Los AngelesLos Angeles, CAOU Health Sciences CenterOklahoma City, OKSt. Louis OvarianCancer AwarenessResearch GrantKathy Jean WarnickOvarian CancerResearch Grant$50,000$25,000“Identification of Ovarian SurfaceEpithelial Stem Cells and theirRole in Cancer Initiation”“The Role of RibonucleotideReductase Regulatory Subunit1 and Excision Repair Cross-Complementation Group 1 inDetermining Chemo-Sensitivity inOvarian Cancer”Sean Dowdy, MDMayo ClinicRochester, MNSusan A. OldeEndometrial CancerResearch Grant$50,000“Evolution of the TumorigenicEffects of DNA Methyltransferase3B in Endometrial Cancer”Alpa Nick, MDThe University of TexasMD Anderson CancerCenter Houston, TXAnn Schreiber OvarianCancer Research Grant$50,000“Breath Biomarkers for Detectionof Ovarian Cancer”John Liao, MD, PhDUniversity of PennsylvaniaPhiladelphia, PAFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000“Human Peripheral BloodLymphocytes Expressing a MurineAnti-p53 T Cell Receptor forOvarian Cancer Immunotherapy”2008–2009Robert Wenham, MDCharles Landen, MDMoffitt Cancer CenterTampa, FLUniversity of AlabamaBirmingham, ALMolly Cade OvarianCancer Research GrantSarah BiedenharnOvarian CancerResearch Grant inhonor of Ellen Smith,MD$50,000$50,000“The Role of 14.3.3 in OvarianCancer Cell AKT-MediatedApoptosis; A Potential New Targetfor Overcoming Chemoresistance”“Targeting the Notch Pathway inOvarian Cancer Stem Cells”Premal Thaker, MDWashington UniversitySchool of MedicineSt. Louis, MOSt. Louis OvarianCancer AwarenessResearch Grant$40,000“Therapeutic Targeting of StressFactors in Ovarian CancerPatients”Dineo Khabele, MDVanderbilt UniversityNashville, TNMary-Jane Welkerand Sherri’s From AWhisper to a RoarOvarian CancerResearch Grant$25,000“Selective Targeting of HDAC3 inOvarian Cancer”21

Research Grants and Awards History Report (continued)RECIPIENT INSTITUTION AWARD AMOUNT TITLE2010–2011W. RuprechtWiedemeyer, PhDMai Xu, MD, PhDCedars-Sinai Medical CenterWashington UniversitySchool of MedicineMary-Jane WelkerOvarian CancerResearch Grant; Specialthanks to Dr. LynneKnowlesGail MacNeil KOHResearch Grant forEarly Detection ofOvarian Cancer$50,000$50,000Biomarkers Predicting Responseto Cyclin-Dependent KinaseInhibitors in Ovarian CancerDevelopment of Reagents forOvarian Cancer Imaging andTargeted TherapyJustin Bottsford-Miller,MDUniversity of TexasMD Anderson CancerCenterOvarian CancerNational AllianceOvarian CancerResearch Grant$50,000Fuel on the Fire: Understandingthe Influence of Platelets onChemotherapy Response inOvarian CancerMichael Goodheart, MDUniversity of IowaCarol’s CauseEndometrial CancerResearch Grant$25,000Wnt/Lef-1 Regulation ofEndometrial Gland Growth2011–2012Petar Jelinic, PhDErin King, MD, MPHSloan-Kettering Institute forCancer ResearchUniversity of TexasMD Anderson CancerCenterFlorence & MarshallSchwid Ovarian CancerResearch GrantSt. Louis OvarianCancer AwarenessResearch Grant$50,000$25,000EMSY-mediated Suppressionof Homology-directed Repair-Expanding the Arena of PARPInhibitors in Ovarian CancerProgestagen-AssociatedEndometrial Protein (PAEP): ANovel Tumor Suppressor Genewith Therapeutic Implicationsin Low-grade Serous OvarianCarcinomasAndras Ladanyi, MD,PhDUniversity of ChicagoHospitalsAmgen Ovarian CancerResearch Grant$50,000The Role of PlasminogenActivator Inhibitor-1 Expressionin Cancer-Associated Fibroblastsin High-Grade Serous OvarianCancersJung-Min Lee, MDNational Cancer InstituteCaring Together,NY Ovarian CancerResearch Grant$50,000High γH2AX/Rad51 RatioIs a Predictive Biomarker forResponse to PARP InhibitorTherapy in High Grade SerousMullerian CancersAngeles Alvarez Secord,MD, MHScDuke UniversityFlorence & MarshallSchwid Ovarian CancerResearch Grant$50,000Biomarker Discovery to DirectBevacizumab Therapy in OvarianCancer – Blood-based AngiomeProfiling2012–2013Paul-Joseph Aspuria,PhDThanh Dellinger, MDCedars-Sinai Medical CenterBeckman Research Instituteof City of HopeLynette Medlin-Brumfield/Mary-JaneWelker OvarianCancer Early DetectionResearch GrantAthena’s Run for GYNCancers, OvarianCancer Research Grant$50,000$50,000Development of a Non-IonizingRadiation Imaging Modality forEarly Ovarian Cancer DetectionTherapeutic Potential of TargetingTwist1 in Preventing Metastasisand Chemoresistance in EpithelialOvarian Cancer (EOC)Michael Goldberg, PhDDana-Farber CancerInstituteCaring Together,NY Ovarian CancerResearch Grant$50,000A Novel Combinatorial Approachto Address Immunosuppressionand Proliferation in OvarianCancer23

Research Grants and Awards History Report (continued)RECIPIENT INSTITUTION AWARD AMOUNT TITLEJesus Gonzalez-Bosquet,MD, PhDH. Lee Moffitt Cancer Center& Research Inst.St. Louis OvarianCancer AwarenessResearch Grant$25,000Identification of RegulatoryElements Associated with OvarianCancer Chemo-response ThroughIntegration of Biological Data2012–2013Meera Nanjundan, PhDCaitlin Stashwick, MDUniversity of South FloridaThe University ofPennsylvaniaThe Braverman/RudnickFamily Grant in OvarianCancer ResearchJohanna’s Fund OvarianCancer Research Grant$25,000$25,000Role of Autophagy in theTransition from Endometriosis toEndometriosis-Associated OvarianCancersOvercoming B7-H4 MediatedT-cell Inhibition and TumorImmune Evasion in OvarianCancer with a Novel ChimericProteinYunfei Wen, PhDUniversity of TexasMD Anderson CancerCenterAmgen Ovarian CancerResearch Grant$50,000Promoting Suicidal Autophagyin Ovarian Cancer by BlockingProlactinRebecca C. Arend, MDUniversity of Alabama atBirminghamWeRoc/OChO OvarianCancer Research Grant$50,000Wnt/B-catenin pathway as a targetfor the treatment of ovarian cancerStephanie Jean, MDUniversity of PennsylvaniaSt. Louis OvarianCancer AwarenessResearch Grant$50,000Understanding BRCA-associatedtumor evolution using targetednext generation sequencing ofnormal, precursor, and malignanttissueMarianne Kim, PhDNational Cancer InstituteAmgen Ovarian CancerResearch Grant$50,000From therapeutic targets to clinicalstrategies2013–2014Paula S. Lee, MD, PhDDuke UniversityGenentech OvarianCancer Research Grant$50,000A Pilot Study on H.O.P.E.: HelpingOvarian Cancer Patients CopeDuring Disease RecurrenceSherry Y. Wu, PhDUniversity of TexasMD Anderson CancerCenterCaring Together,NY Ovarian CancerResearch Grant$100,000Novel microRNA-based immunostimulatorystrategies for treatmentof ovarian cancerMelinda S. Yates, PhDUniversity of TexasMD Anderson CancerCenterRoberta DetzEndometrial CancerResearch Grant$50,000Endometrial specific knockoutof MSH2: Characterization of amouse model for lynch syndrome24

Research Grants and Awards History Report (continued)RECIPIENT INSTITUTION AWARD AMOUNT TITLEPaiman PeterGhoroghchian, MD, PhDDana-Farber CancerInstitute (DFCI)/Massachusetts Instituteof Technology (MIT)Amgen Ovarian CancerResearch Grant$50,000Novel therapies for platinumresistant ovarian cancerYi-Wen Huang, PhDMedical College ofWisconsinAthena’s RunEndometrial CancerResearch Grant$50,000Targeting the miR-137-KDM1 axisas a therapeutic strategy for highgradeendometrial carcinomas2014–2015Piotr Dorniak, PhDXiaowen Hu, PhDThe University of TexasMD Anderson CancerCenterUniversity of Pennsylvania2014–15 CaringTogether, NY OvarianCancer Research GrantGynecologic CancerResearch Grant$100,000$45,000Tumor neurogenesis: novelmechanisms for targeting ovariancancerCharacterization of a novelrecurrent noncoding genomicalteration in high grade serousovarian cancerDmitriy Zamarin, MD,PhDMemorial Sloan KetteringCancer CenterThe Judith LiebenthalRobinson OvarianCancer FoundationResearch Grant$50,000Immunologic biomarkers ofresponse to immunotherapyin platinum-resistant relapsedovarian cancerKatherine Fuh, MD, PhDWashington UniversitySchool of MedicineSt. Louis OvarianCancer AwarenessResearch Grant$75,000Functional genomics of metastaticovarian cancer25

National Cancer Institute Fellows History ReportRECIPIENT AWARD AMOUNT TITLE1995–1999Terri Cornelison, MDGCF/NCI Research TrainingFellowship$100,000“Prevention of Late Effect Radiation Fibrosis byCytokine Inhibition”1999–2003Monica Brown, MDGCF/NCI Research TrainingFellowship$100,000“Gene Expression Profiling in OvarianNeoplasms”2000–2004Ginger Gardner, MDGCF/NCI Research TrainingFellowship$100,000“The Development and Characterization ofNovel Retinoids for the Chemoprevention andTreatment of Ovarian Cancer”2000–2004Amir Jazaeri, MDGCF/NCI Research TrainingFellowship$100,000“Use of cDNA Microarrays in Evaluation ofOvarian Cancer”2001–2005Kristin Zorn, MDGCF/NCI Research TrainingFellowship$100,000“Gene Expressions Profile of Ovarian CancerHistologic Suptypes”NOTE: The salary of each fellow was matched equally by NCI.National Cancer Institute Scholars History ReportRECIPIENT INSTITUTION AWARD AMOUNT2006–2008Jesus Gonzalez Bosquet, MD, PhDMayo ClinicRochester, MNGCF/NCI Scholar’s Program $100,000NOTE: The salary of this scholar was matched equally by NCI.26

Recipients of Outstanding Paper by a Resident or FellowHistory ReportYEARRECIPIENTYEARRECIPIENT1994 Jeffrey Hines, MD2006 Michael Milam, MD1995 Jeffrey Skilling, MD2006 Charles Landen, MD1996 Jeffrey Skilling, MD2007 William Merritt, MD1997 Cheryl Bailey, MD2007 Liz Han, MD1998 J. Rebecca Liu, MD2008 Kimberly Resnick, MD1999 David Kushner, MD2008 Liz Han, MD2000 Douglas Levine, MD2009 Jason Cory Barnett, MD2001 Warner Huh, MD2009 Karen McLean, MD, PhD2002 Annie Yessaian, MD2010 Barbara Norquist, MD2003 Nicholas Lambrou, MD2011 Nicole Fleming, MD2003 Kristin Zorn, MD2012 Stephanie L. Wethington, MD2004 Rahel Ghebre, MD2014 Justin Bottsford-Miller, MD2005 Lynne Knowles, MD2014 Linda Hong, MD2005 Premal Thaker, MDFoundation for Women’s Cancer/OCRF Grant for Early Detection ofOvarian Cancer History ReportRECIPIENT INSTITUTION AWARD AMOUNT TITLE2008–2009Barbara Goff, MDUniversity of WashingtonFoundation for Women’sCancer/OCRF Grantfor Early Detection ofOvarian Cancer$300,000Symptom Triggered Screening forOvarian Cancer: A Pilot Study ofFeasibility and AcceptabilityPerlman Family CCARE Lynch Syndrome Research PrizeHistory ReportYEARRECIPIENTYEARRECIPIENT2012–2013 Miya M. Frick2014–2015 Joshua G. Cohen, MD2013–2014 Erin E. Greenberg, MD27

Dr. John L. Lewis, Jr./William F. O’Connor FoundationResearch Prize History ReportYEARRECIPIENTYEARRECIPIENT2013–2014 Mythili Koneru, MD2014–2015 Kemi M. Doll, MDJohn L. Lewis, Jr., MD Presidential Award History ReportYEARRECIPIENTYEARRECIPIENT2013–2014 Jerome Belinson, MD2014–2015 Ramez Eskander, MDMargaret Greenfield/Carmel Cohen, MD“Excellence in Ovarian Cancer Prize” History ReportRECIPIENT INSTITUTION AWARD TITLE2004–2005George Coukos, MD,PhDUniversity of PennsylvaniaPhiladelphia, PAMargaret Greenfield/CarmelCohen, MD “Excellence inOvarian Cancer Research Prize”“Impact of Cytotoxic Chemotherapyon Vaccine Therapy Strategies inEpithelial Ovarian Cancer”2005–2006Andrew Berchuck, MDDuke University MedicalCenterDurham, NCMargaret Greenfield/CarmelCohen, MD “Excellence inOvarian Cancer Research Prize”“Molecular Epidemiology of OvarianCancer”2006–2007Anil Sood, MDThe University of TexasMD Anderson Cancer CenterHouston, TXMargaret Greenfield/CarmelCohen, MD “Excellence inOvarian Cancer Research Prize”“Role of FAK Expression inInvasion and Progression”2007–2008Beth Karlan, MDCedars-Sinai Medical CenterLos Angeles, CAMargaret Greenfield/CarmelCohen, MD “Excellence inOvarian Cancer Research Prize”“Characterization of a NovelOvarian Inhibitory Substance”2008–2009Ronald Alvarez, MDUniversity of AlabamaBirmingham, ALMargaret Greenfield/CarmelCohen, MD “Excellence inOvarian Cancer Research Prize”“Melanoma DifferentiationAssociated-7 (mda-7) Gene: ANovel Multifunctional Anti-TumorAgent for Ovarian Cancer”2009–2010Elizabeth Swisher, MDUniversity of WashingtonSeattle, WAMargaret Greenfield/CarmelCohen, MD “Excellence inOvarian Cancer Research Prize”“Impact of Epigenetic Modulationof DNA Repair Genes onChemoresistance and Survival inOvarian Cancer”2010–2011Robert Coleman, MDThe University of TexasMD Anderson Cancer CenterMargaret Greenfield/CarmelCohen, MD “Excellence inOvarian Cancer Research Prize”“Therapeutic Gene Silencing withsiRNA in Ovarian Carcinoma28

Foundation for Women’s Cancer “Excellence in Ovarian CancerResearch Prize” in honor of Ronald Alvarez, MD History ReportRECIPIENT INSTITUTION AWARD TITLE2011–2012Ernst Lengyel, MD,PhDUniversity of ChicagoFoundation for Women’s CancerExcellence in Ovarian CancerResearch Prize“Establishment of a Peritoneal 3DCulture to Investigate Attachmentand Invasion of Ovarian CancerCells”2012–2013Douglas A. Levine, MDMemorial Sloan-KetteringCancer CenterFoundation for Women’s CancerExcellence in Ovarian CancerResearch Prize in Honor ofRonald Alvarez, MD“MicroRNA Gene Expression inAdvanced Ovarian Cancer”2013–2014Janice Rebecca Liu,MDUniversity of MichiganMedical CenterFoundation for Women’s Cancer/Norma Livingston OvarianCancer Foundation Excellence inOvarian Cancer Research Prizein Honor of Ronald Alvarez, MD“Gynecologic Cancer Foundation/Susan G. Komen Breast CancerFoundation Career DevelopmentAward: Resveratrol InducedApoptosis and Autophagocytosis inOvarian and Breast Cancer”2014–2015Jason Dennis Wright,MDColumbia University Collegeof Physicians and SurgeonsFoundation for Women’s Cancer/Norma Livingston OvarianCancer Foundation Excellence inOvarian Cancer Research Prizein Honor of Ronald Alvarez, MD“Measuring the Quality of SurgicalCare for Women with OvarianCancer”Claudia Cohen Research Foundation Prize for OutstandingGynecologic Cancer Researcher History ReportRECIPIENT INSTITUTION AWARD TITLE2009–2010Paul Goodfellow, PhDWashington UniversitySchool of MedicineSt. Louis, MOClaudia Cohen ResearchFoundation Prize forOutstanding GynecologicCancer Researcher“Genetic and Epigenetic Events Associated with EndometrialTumorigenesis and Endometrial Cancer Progression”2010–2011Anil Sood, MDUniversity of TexasMD Anderson CancerCenterClaudia Cohen ResearchFoundation Prize forOutstanding GynecologicCancer Researcher“Ovarian Cancer Biology; Angiogenesis; Nanotechnology;Translational Research”2011–2012George Coukos, MD,PhDUniversity ofPennsylvaniaClaudia Cohen ResearchFoundation Prize forOutstanding GynecologicCancer Researcher“Prevention, Early Detection and Treatment of Ovarian Cancer”2012–2013Robert C. Bast Jr., MDUniversity of TexasMD Anderson CancerCenterClaudia Cohen ResearchFoundation Prize forOutstanding GynecologicCancer Researcher“Cellular and Molecular Biology of Ovarian and Breast Cancer;Tumor Biomarkers; Medical Oncology with Emphasis on Caringfor Patients with Ovarian and Breast Cancer; TranslationalResearch with Emphasis on Academe-Pharma Interactions andon Mentoring Physician-scientists, Clinician-investigators anTranslational PhDs”2013–2014Andrew Berchuck, MDDuke University MedicalCenterClaudia Cohen ResearchFoundation Prize forOutstanding GynecologicCancer Researcher“Molecular Pathogenesis of Ovarian Cancer”2014–2015Beth Y. Karlan, MDCedars-Sinai MedicalCenterClaudia Cohen ResearchFoundation Prize forOutstanding GynecologicCancer Researcher“Characterization of a Novel Ovarian Inhibitory Substance”29

FOUNDATION FOR WOMEN’S CANCEREXECUTIVE COMMITTEEChairmanDavid G. Mutch, MDWashington UniversityTreasurerDavid H. Moore, MDGynecologic Oncology of IndianaDevelopment ChairWilliam J. Hoskins, MDMemorial Sloan-Kettering Cancer CenterAwards Committee ChairAnil K. Sood, MDThe University of Texas MD Anderson Cancer CenterCommunications Committee ChairCarol L. Brown, MDMemorial Sloan-Kettering Cancer CenterAdvocacy Committee ChairLinda R. Duska, MDUniversity of Virginia Health SystemBOARD OF DIRECTORSMichael J. Birrer, MD, PhDMassachusetts General Hospital/Harvard UniversityIlana Cass, MDUCLA Cedars Sinai Medical CenterDavid M. Gershenson, MDThe University of Texas MD Anderson Cancer CenterCharles N. Landen Jr., MDThe University of Alabama at BirminghamGeorge Larry Maxwell, MDInova Fairfax Hospital Women’s CenterMatthew A. Powell, MDWashington University School of MedicineLaurel W. Rice, MDUniversity of WisconsinFidel Valea, MDDuke University Medical CenterRobert Coleman, MD, Ex-OfficioThe University of Texas MD Anderson Cancer CenterJeffrey M. Fowler, MD, Ex-OfficioThe Ohio State UniversityHEADQUARTERS STAFFKaren Carlson, Executive DirectorLauren Herron, Administrative ManagerTerri Horton-O’Connell, Director of Foundation andCorporate RelationsSharon Krinsky, Director of PhilanthropyMarsha Tanner Wilson, Director of Communications andAdvocacy RelationsDina Tizzard, Program ManagerThe Society of Gynecologic Oncology’s (SGO) Foundation for Women’s Cancer is dedicated to increasing public awareness of gynecologiccancer risk awareness, prevention, early detection and optimal treatment. Founded by SGO in 1991, the Foundation for Women’s Cancer is anonprofit organization that also provides funding for gynecologic cancer research and training, as well as educational programs and resources.30

ation for Women’s Cancer Gynecologic Cancer Awareic Cancer Awareness Research Education Foundationion Foundation for Women’s Cancer Gynecologic Canynecologic Cancer Awareness Research Education Fourch Education Foundation for Women’s Cancer Gynecen’s Cancer Gynecologic Cancer Awareness Researcwareness Research Education Foundation for Women’sation for Women’s Cancer Gynecologic Cancer Awareic Cancer Awareness Research Education Foundationion Foundation for Women’s Cancer Gynecologic Canynecologic Cancer Awareness Research Education Fourch Education Foundation for Women’s Cancer Gynecen’s Cancer Gynecologic Cancer Awareness Researcwareness Research Education Foundation for Women’sation for Women’s Cancer Gynecologic Cancer Awareic Cancer Awareness Research Education FoundationFoundation for Women’s Cancer230 W. Monroe Street, Suite 2528on Foundation for Women’s Cancer Gynecologic CancChicago, IL 60606-4902Phone: 312.578.1439 Fax: 312.578.9769ynecologic Cancer Awareness Research Education Fouresearch@foundationforwomenscancer.orgrch Education Foundation foundationforwomenscancer.org for Women’s Cancer Gynecen’s Cancer Gynecologic Cancer Awareness Researcwareness Research Education Foundation for Women’sThe Foundation for Women’s Cancer gratefully acknowledges the following:Belinda Sue Fund; Caring Together, NY; Carol’s Cause; Claudia Cohen Research Foundation;ation for Women’s Cancer Gynecologic Cancer Awarethe Dickens Fund of the Donnelley Foundation; Norma Livingston Ovarian Cancer Foundation;Ovarcome; the Perlman Family; St. Louis Ovarian Cancer Awareness; the Welker Family;ic Cancer Awareness William F. O’Connor Foundation; Research Women Encouraging Education Research in Ovarian CancerFoundationion Foundation for Women’s Cancer Gynecologic Can